InnoMedica Schweiz AG
🇨ðŸ‡Switzerland
- Country
- 🇨ðŸ‡Switzerland
- Ownership
- Subsidiary
- Established
- 1988-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.ipag.ch
Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease
- First Posted Date
- 2024-05-29
- Last Posted Date
- 2024-05-29
- Lead Sponsor
- InnoMedica Schweiz AG
- Target Recruit Count
- 40
- Registration Number
- NCT06431971
- Locations
- 🇨ðŸ‡
Neurologisches Institut Konolfingen, Konolfingen, Switzerland
Safety Evaluation of Intravenous Talineuren (TLN) in Parkinson's Disease-affected Patients
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2024-03-15
- Lead Sponsor
- InnoMedica Schweiz AG
- Target Recruit Count
- 22
- Registration Number
- NCT04976127
- Locations
- 🇨ðŸ‡
Neurologisches Institut Konolfingen, Konolfingen, Bern, Switzerland
© Copyright 2025. All Rights Reserved by MedPath